SMRxT is a medication adherence company primarily serving US markets. The company operates a hardware adherence solution, as well as a platform that powers the delivery of Adherence Media™, allowing clients to customize, test and advance intervention content and protocols specific to each patient. As part of this adherence system, SMRxT offers Nomi, a smart pill bottle with multiple sensors that collect information on time, movement and temperature in addition to medication weight to support adherence tracking.
How it works
Nomi smart pill bottles must be filled by a pharmacist and then distributed to the patient. The bottle automatically tracks adherence via a cellular data connection from the bottle to an online database. This data can then be shared with clinicians and family members. The system provides automated and real–time messages, interventions and captures patient feedback.
SMRxT has partnered with Verizon, who have showcased the smart pill bottle.
Nomi has been scored below according to it’s ability to serve the TB market for LMICs along Fit for Purpose and Technical Specifications metrics. Note that higher scores equate to a greater ability to serve the market. For example, if a product scores well in the Provider Burden subcategory, that means that the burden for the provider is low.
For full descriptions of the sub-categories, see the 2021 DAT Market Landscape.
Fit for Purpose
Barriers to Entry50%
- Low burden for the patient and low technological requirements
- No charging necessary
- Smart pill bottle is easily portable, tracks adherence automatically, and integrates with other platform
- Not easily utilized with blister packed TB meds
- Sensitive to humidity, sun and temperature extremes
- Device needs to remain upright to weigh correctly